NCT02216188View on ClinicalTrials.gov

Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2015

Conditions

Parkinson's Disease

Interventions

BIOLOGICAL

AFFITOPE® PD01A

s.c. injection

OTHER

Control

Untreated control group

Trial Locations (1)

Unknown

Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Skodagasse 32, 1080 Vienna, Vienna

All Listed Sponsors

lead

Affiris AG

INDUSTRY

NCT02216188 - Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity | Biotech Hunter | Biotech Hunter